PURPOSE: To investigate the function of MYO7A in human RPE cells and to test the validity of using shaker1 RPE in preclinical studies on therapies for Usher syndrome 1B by comparing human and mouse cells. METHODS: MYO7A was localized by immunofluorescence. Primary cultures of human and mouse RPE cells were used to measure melanosome motility and rod outer segment (ROS) phagocytosis and digestion. MYO7A was knocked down in the human RPE cells by RNAi to test for a mutant phenotype in melanosome motility. RESULTS: The distribution of MYO7A in the RPE of human and mouse was found to be comparable, both in vivo and in primary cultures. Primary cultures of human RPE cells phagocytosed and digested ROSs with kinetics comparable to that of primary cultures of mouse RPE cells. Melanosome motility was also comparable, and, after RNAi knockdown, consisted of longer-range fast movements characteristic of melanosomes in shaker1 RPE. CONCLUSIONS: The localization and function of MYO7A in human RPE cells is comparable to that in mouse RPE cells. Although shaker1 retinas do not undergo degeneration, correction of mutant phenotypes in the shaker1 RPE represents a valid preclinical test for potential therapeutic treatments.
PURPOSE: To investigate the function of MYO7A in humanRPE cells and to test the validity of using shaker1RPE in preclinical studies on therapies for Usher syndrome 1B by comparing human and mouse cells. METHODS:MYO7A was localized by immunofluorescence. Primary cultures of human and mouseRPE cells were used to measure melanosome motility and rod outer segment (ROS) phagocytosis and digestion. MYO7A was knocked down in the humanRPE cells by RNAi to test for a mutant phenotype in melanosome motility. RESULTS: The distribution of MYO7A in the RPE of human and mouse was found to be comparable, both in vivo and in primary cultures. Primary cultures of humanRPE cells phagocytosed and digested ROSs with kinetics comparable to that of primary cultures of mouseRPE cells. Melanosome motility was also comparable, and, after RNAi knockdown, consisted of longer-range fast movements characteristic of melanosomes in shaker1RPE. CONCLUSIONS: The localization and function of MYO7A in humanRPE cells is comparable to that in mouseRPE cells. Although shaker1 retinas do not undergo degeneration, correction of mutant phenotypes in the shaker1RPE represents a valid preclinical test for potential therapeutic treatments.
Authors: L M Astuto; M D Weston; C A Carney; D M Hoover; C W Cremers; M Wagenaar; C Moller; R J Smith; S Pieke-Dahl; J Greenberg; R Ramesar; S G Jacobson; C Ayuso; J R Heckenlively; M Tamayo; M B Gorin; W Reardon; W J Kimberling Journal: Am J Hum Genet Date: 2000-11-01 Impact factor: 11.025
Authors: Clare E Futter; José S Ramalho; Gesine B Jaissle; Mathias W Seeliger; Miguel C Seabra Journal: Mol Biol Cell Date: 2004-02-20 Impact factor: 4.138
Authors: David S Williams; Tomas S Aleman; Concepción Lillo; Vanda S Lopes; Louise C Hughes; Edwin M Stone; Samuel G Jacobson Journal: Invest Ophthalmol Vis Sci Date: 2009-03-25 Impact factor: 4.799
Authors: Concepcion Lillo; Junko Kitamoto; Xinran Liu; Elizabeth Quint; Karen P Steel; David S Williams Journal: Adv Exp Med Biol Date: 2003 Impact factor: 2.622
Authors: Ivy S Samuels; Brent A Bell; Gwen Sturgill-Short; Lindsey A Ebke; Mary Rayborn; Lanying Shi; Patsy M Nishina; Neal S Peachey Journal: Invest Ophthalmol Vis Sci Date: 2013-11-01 Impact factor: 4.799
Authors: V S Lopes; S E Boye; C M Louie; S Boye; F Dyka; V Chiodo; H Fofo; W W Hauswirth; D S Williams Journal: Gene Ther Date: 2013-01-24 Impact factor: 5.250